Gut microbiota: Description, role and pathophysiologic implications;Le microbiote intestinal : description, rôle et implication physiopathologique

Revue de Medecine Interne

Volumn 37, Issue 6, 2016, Pages 418-423

  Landman, C ^a   Quevrain E ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Dysbiosis; Gut microbiota; Immune system; Inflammatory bowel diseases; Obesity

Indexed keywords

XENOBIOTIC AGENT;

BACTERIAL COLONIZATION; BACTERIUM CULTURE; BILE ACID METABOLISM; DYSBIOSIS; FERMENTATION; HIGH THROUGHPUT SEQUENCING; IMMUNE SYSTEM; INFORMATION PROCESSING; INTESTINE FLORA; NONHUMAN; PATHOPHYSIOLOGY; SHORT SURVEY; SPECIES COMPOSITION; COMPLICATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE; METABOLISM; MICROBIOLOGY; NEWBORN; OBESITY; PATHOLOGY; PHYSIOLOGY;

DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; INTESTINES; OBESITY;

EID: 84983094200     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2015.12.012     Document Type: Short Survey

References (29)

1. [1] Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., et al. Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
2. [2] Nielsen, H.B., Almeida, M., Juncker, A.S., Rasmussen, S., Li, J., Sunagawa, S., et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol 32 (2014), 822–828.
3. [3] Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
4. [4] Hooper, L.V., Bacterial contributions to mammalian gut development. Trends Microbiol 12 (2004), 129–134.
5. [5] Macpherson, A.J., Harris, N.L., Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4 (2004), 478–485.
6. [6] Gaboriau-Routhiau, V., Rakotobe, S., Lecuyer, E., Mulder, I., Lan, A., Bridonneau, C., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31 (2009), 677–689.
7. [7] Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331 (2011), 337–341.
8. [8] Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
9. [9] Pryde, S.E., Duncan, S.H., Hold, G.L., Stewart, C.S., Flint, H.J., The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217 (2002), 133–139.
10. [10] Christl, S.U., Murgatroyd, P.R., Gibson, G.R., Cummings, J.H., Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology 102 (1992), 1269–1277.
11. [11] Lichtenstein, A.H., Intestinal cholesterol metabolism. Ann Med 22 (1990), 49–52.
12. [12] Ridlon, J.M., Kang, D.J., Hylemon, P.B., Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47 (2006), 241–259.
13. [13] Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
14. [14] Backhed, F., Ley, R.E., Sonnenburg, J.L., et al. Host-bacterial mutualism in the human intestine. Science 307 (2005), 1915–1920.
15. [15] Marchesi, J.R., Dutilh, B.E., Hall, N., Peters, W.H.M., Roelofs, R., Boleij, A., et al. Towards the human colorectal cancer microbiome. PLoS One, 2011, 6.
16. [16] Nougayrede, J.P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313 (2006), 848–851.
17. [17] Arthur, J.C., Perez-Chanona, E., Muhlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.J., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338 (2012), 120–123.
18. [18] Wang, L., Christophersen, C.T., Sorich, M.J., Gerber, J.P., Angley, M.T., Conlon, M.A., Low relative abundances of the mucolytic bacterium akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microb 77 (2011), 6718–6721.
19. [19] Williams, B.L., Hornig, M., Parekh, T., Lipkin, W.I., Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio, 2012, 3.
20. [20] Rao, A.V., Bested, A.C., Beaulne, T.M., Katzman, M.A., Iorio, C., Berardi, J.M., et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog, 2009, 1.
21. [21] Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (2013), 1451–1463.
22. [22] Seksik, P., [Gut microbiota and IBD]. Gastroenterol Clin Biol 34:Suppl. 1 (2010), S44–S51.
23. [23] Sokol, H., Seksik, P., Furet, J.P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15 (2009), 1183–1189.
24. [24] Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., Di Martino, P., Desreumaux, P., et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115 (1998), 1405–1413.
25. [25] Rajca, S., Grondin, V., Louis, E., Vernier-Massouille, G., Grimaud, J.C., Bouhnik, Y., et al. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm Bowel Dis 20 (2014), 978–986.
26. [26] Dinh, A., Bouchand, F., Le Monnier, A., [Current treatment and epidemiology of Clostridium difficile infections]. Rev Med Interne 36 (2015), 569–602.
27. [27] Rossen, N.G., MacDonald, J.K., de Vries, E.M., D'Haens, G.R., de Vos, W.M., Zoetendal, E.G., et al. Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review. World J Gastroenterol 21 (2015), 5359–5371.
28. [28] Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L.G., Gratadoux, J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105 (2008), 16731–16736.
29. [29] Quévrain, E., Maubert, M.A., Michon, C., Chain, F., Marquant, R., Tailhades, J., et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut, 2015.